+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1bi7 | ||||||
---|---|---|---|---|---|---|---|
タイトル | MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE STRUCTURE OF THE CDK6-P16INK4A TUMOR SUPPRESSOR COMPLEX | ||||||
![]() |
| ||||||
![]() | COMPLEX (KINASE/ANTI-ONCOGENE) / CYCLIN DEPENDENT KINASE / CYCLIN DEPENDENT KINASE INHIBITORY PROTEIN / CDK / INK4 / CELL CYCLE / MULTIPLE TUMOR SUPPRESSOR / MTS1 / COMPLEX (KINASE-ANTI-ONCOGENE) / COMPLEX (KINASE-ANTI-ONCOGENE) complex | ||||||
機能・相同性 | ![]() positive regulation of macrophage apoptotic process / senescence-associated heterochromatin focus / cyclin D2-CDK6 complex / cyclin D3-CDK6 complex / Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 / Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 / cyclin D1-CDK6 complex / cell dedifferentiation / Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 / Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 ...positive regulation of macrophage apoptotic process / senescence-associated heterochromatin focus / cyclin D2-CDK6 complex / cyclin D3-CDK6 complex / Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 / Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 / cyclin D1-CDK6 complex / cell dedifferentiation / Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 / Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 / Drug-mediated inhibition of CDK4/CDK6 activity / FBXO family protein binding / lateral ventricle development / negative regulation of phosphorylation / positive regulation of smooth muscle cell apoptotic process / negative regulation of myeloid cell differentiation / negative regulation of cyclin-dependent protein serine/threonine kinase activity / type B pancreatic cell development / negative regulation of monocyte differentiation / astrocyte development / dentate gyrus development / regulation of cell motility / cyclin-dependent protein serine/threonine kinase inhibitor activity / gliogenesis / Regulation of RUNX1 Expression and Activity / regulation of hematopoietic stem cell differentiation / positive regulation of cell-matrix adhesion / generation of neurons / Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) / regulation of G1/S transition of mitotic cell cycle / negative regulation of cell cycle / Transcriptional Regulation by VENTX / negative regulation of cellular senescence / replicative senescence / negative regulation of cell differentiation / negative regulation of cell-matrix adhesion / negative regulation of osteoblast differentiation / hematopoietic stem cell differentiation / NF-kappaB binding / cyclin-dependent kinase / cyclin-dependent protein serine/threonine kinase activity / Regulation of MITF-M-dependent genes involved in cell cycle and proliferation / cyclin-dependent protein kinase holoenzyme complex / ruffle / regulation of G2/M transition of mitotic cell cycle / Notch signaling pathway / cyclin binding / regulation of erythrocyte differentiation / negative regulation of cell growth / Oncogene Induced Senescence / response to virus / G1/S transition of mitotic cell cycle / positive regulation of fibroblast proliferation / negative regulation of epithelial cell proliferation / Cyclin D associated events in G1 / cellular senescence / T cell differentiation in thymus / regulation of gene expression / Senescence-Associated Secretory Phenotype (SASP) / Oxidative Stress Induced Senescence / Ras protein signal transduction / regulation of cell cycle / protein phosphorylation / negative regulation of cell population proliferation / cell division / protein serine kinase activity / negative regulation of DNA-templated transcription / centrosome / positive regulation of gene expression / protein kinase binding / negative regulation of transcription by RNA polymerase II / signal transduction / RNA binding / nucleoplasm / ATP binding / nucleus / cytosol / cytoplasm 類似検索 - 分子機能 | ||||||
生物種 | ![]() | ||||||
手法 | ![]() ![]() ![]() ![]() | ||||||
![]() | Russo, A.A. / Tong, L. / Lee, J.O. / Jeffrey, P.D. / Pavletich, N.P. | ||||||
![]() | ![]() タイトル: Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. 著者: Russo, A.A. / Tong, L. / Lee, J.O. / Jeffrey, P.D. / Pavletich, N.P. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 81.6 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 62.3 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
---|
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 | ![]()
| ||||||||
単位格子 |
|
-
要素
#1: タンパク質 | 分子量: 36987.328 Da / 分子数: 1 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() 発現宿主: ![]() ![]() 株 (発現宿主): HI5 参照: UniProt: Q00534, 転移酵素; リンを含む基を移すもの; キナーゼ(アルコールにつなげるもの) |
---|---|
#2: タンパク質 | 分子量: 16555.586 Da / 分子数: 1 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() ![]() |
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 3.98 Å3/Da / 溶媒含有率: 69.08 % | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | *PLUS 温度: 4 ℃ / pH: 7.5 / 手法: 蒸気拡散法, ハンギングドロップ法 | ||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
回折 | 平均測定温度: 110 K |
---|---|
放射光源 | 由来: ![]() ![]() ![]() |
検出器 | 検出器: CCD / 日付: 1997年1月1日 / 詳細: MIRRORS |
放射 | モノクロメーター: MIRRORS / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 0.908 Å / 相対比: 1 |
反射 | 解像度: 3.4→20 Å / Num. obs: 12443 / % possible obs: 97.7 % / Observed criterion σ(I): 0 / 冗長度: 5.5 % / Rsym value: 0.068 / Net I/σ(I): 17.7 |
反射 シェル | 解像度: 3.4→3.52 Å / 冗長度: 4.1 % / Mean I/σ(I) obs: 6.9 / Rsym value: 0.33 / % possible all: 96.2 |
反射 | *PLUS Num. measured all: 68633 / Rmerge(I) obs: 0.068 |
反射 シェル | *PLUS % possible obs: 96.2 % / Rmerge(I) obs: 0.33 |
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: ![]() ![]() 解像度: 3.4→10 Å / Isotropic thermal model: GROUP / 交差検証法: THROUGHOUT / σ(F): 1
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 3.4→10 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ソフトウェア | *PLUS 名称: ![]() | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS |